Company: LRHC
Filing Date: 2025-06-03
Form Type: S-1/A
Source: 0001213900-25-050886
Chunk: 21

Company: La Rosa Holdings Corp.
Filing Date: 2025-06-03
Form: S-1/A
Chunk 21
---
 the Offering.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Use of Proceeds                             |     | We will not receive any of the proceeds from the sale of the common stock registered hereunder. We will receive proceeds upon exercise of the Incremental Warrants. We intend to use such proceeds for general corporate purposes and working capital requirements and other purposes that the Board of Directors deems to be in the best interests of the Company.                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Risk Factors                                |     | An investment in our common stock involves a high degree of risk and could result in a loss of your entire investment. Further, the issuance to, or sale by, the Selling Stockholder of a significant amount of shares being registered in the registration statement, of which this prospectus forms a part, at any given time could cause the market price of our common stock to decline and to be highly volatile, and we do not have the right to control the timing and amount of any sales by the Selling Stockholder of such shares. Prior to making an investment decision, you should carefully consider all of the information in this Prospectus and, in particular, you should evaluate the risk factors set forth under the caption “Risk Factors” beginning on page 12. |
| Trading Symbol on the Nasdaq Capital Market |     | LRHC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

| (1) | Based                                                                                                                             
 on 58,285,266 shares of common stock outstanding as of May 29, 2025. Other than the shares of common stock underlying the Initial 
 Note, it excludes the following as of such date:                                                                                  |

| ● | 2,774,879                                                                                                                        
 shares of our common stock issuable upon the exercise of warrants outstanding, at a weighted average exercise price of $0.58 per 
 share;                                                                                                                           |

| ● | 4,232,161                                                                                                                         
 shares of our common stock issuable upon the exercise of stock options outstanding, at a weighted average exercise price of $1.49 
 per share;                                                                                                                        |

| ● | 763,302                                                                             
 shares of our common stock issuable upon the vesting of restricted stock units; and |

| ● | 5,045,463                                                                                                          
 shares of our common stock reserved for future issuance under our Amended and Restated 2022 Equity Incentive Plan. |

<div align='center'>11

RISK FACTORS</div>

The risks and uncertainties described therein and below could materially adversely affect our business, operating results and financial